ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Exploring Structural Uncertainty With An Open-Source Cost-Effectiveness Model For Rheumatoid Arthritis
Value in Health
◽
10.1016/j.jval.2017.08.2098
◽
2017
◽
Vol 20
(9)
◽
pp. A751
Author(s):
D Incerti
◽
JR Curtis
◽
M Lorenzi
◽
JP Jansen
Keyword(s):
Rheumatoid Arthritis
◽
Cost Effectiveness
◽
Open Source
◽
Structural Uncertainty
◽
Effectiveness Model
Download Full-text
Related Documents
Cited By
References
How to Select the Right Cost-Effectiveness Model? A Systematic Review and Stepwise Approach for Transferring an Existing Health Economic Model for Rheumatoid Arthritis
Value in Health
◽
10.1016/j.jval.2013.08.1639
◽
2013
◽
Vol 16
(7)
◽
pp. A590
Author(s):
H.G.M. van Haalen
◽
A. Tran-Duy
◽
A. Boonen
◽
J.L. Severens
Keyword(s):
Rheumatoid Arthritis
◽
Systematic Review
◽
Health Economic
◽
Cost Effectiveness
◽
Economic Model
◽
Stepwise Approach
◽
Effectiveness Model
◽
Health Economic Model
◽
The Right
Download Full-text
PCN163 IMPROVEMENT OF THE INNOVATION & VALUE INITIATIVE OPEN-SOURCE COST-EFFECTIVENESS MODEL FOR NON-SMALL-CELL LUNG CANCER BASED ON PUBLIC FEEDBACK
Value in Health
◽
10.1016/j.jval.2020.04.1645
◽
2020
◽
Vol 23
◽
pp. S51
Author(s):
M. Linthicum
◽
I. Zhang
◽
J.P. Jansen
Keyword(s):
Lung Cancer
◽
Cost Effectiveness
◽
Small Cell Lung Cancer
◽
Open Source
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Effectiveness Model
Download Full-text
Cost-Effectiveness Model for Evaluating New Diagnostic Tests in the Evaluation of Patients With Inflammatory Arthritis at Risk of Having Rheumatoid Arthritis
Arthritis Care & Research
◽
10.1002/acr.22776
◽
2016
◽
Vol 68
(7)
◽
pp. 927-935
◽
Cited By ~ 6
Author(s):
Jolanda J. Luime
◽
Leander R. Buisman
◽
Mark Oppe
◽
Johanna M. W. Hazes
◽
Maureen P. M. H. Rutten-van Mölken
Keyword(s):
Rheumatoid Arthritis
◽
At Risk
◽
Cost Effectiveness
◽
Diagnostic Tests
◽
Inflammatory Arthritis
◽
Effectiveness Model
Download Full-text
PCN167 - IMPROVEMENT OF AN OPEN-SOURCE COST-EFFECTIVENESS MODEL BASED ON PUBLIC FEEDBACK
Value in Health
◽
10.1016/j.jval.2018.09.250
◽
2018
◽
Vol 21
◽
pp. S42
Author(s):
D. Incerti
◽
J. Shafrin
◽
D.N. Lakdawalla
◽
L. Zhao
◽
M. Linthicum
◽
...
Keyword(s):
Cost Effectiveness
◽
Open Source
◽
Model Based
◽
Effectiveness Model
Download Full-text
PCN169 - A FLEXIBLE OPEN-SOURCE COST-EFFECTIVENESS MODEL FOR METASTATIC EGFR+ NON-SMALL CELL LUNG CANCER
Value in Health
◽
10.1016/j.jval.2018.09.252
◽
2018
◽
Vol 21
◽
pp. S42-S43
Author(s):
J.P. Jansen
◽
D. Incerti
◽
J. Shafrin
◽
A.M. Frederickson
◽
D.N. Lakdawalla
◽
...
Keyword(s):
Lung Cancer
◽
Cost Effectiveness
◽
Small Cell Lung Cancer
◽
Open Source
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Effectiveness Model
Download Full-text
PMS19 Validation of a Cost-Effectiveness MODEL in Rheumatoid Arthritis
Value in Health
◽
10.1016/j.jval.2020.08.1150
◽
2020
◽
Vol 23
◽
pp. S595
Author(s):
S. Sadler
◽
I. Jacob
◽
O. Darlington
◽
E. Still
◽
J. Gordon
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Cost Effectiveness
◽
Effectiveness Model
Download Full-text
A comparative-effectiveness analysis applying a 3 way propensity matching to real-world data from MSBase Registry in preparation for a cost effectiveness model: Patients switching within firstline agents or to Natalizumab or Fingolimod in active RRMS
10.26226/morressier.59a3eda9d462b8028d8957ad
◽
2017
◽
Author(s):
Tim Spelman
Keyword(s):
Cost Effectiveness
◽
Real World
◽
Comparative Effectiveness
◽
Real World Data
◽
World Data
◽
Effectiveness Analysis
◽
Effectiveness Model
◽
Propensity Matching
◽
Comparative Effectiveness Analysis
Download Full-text
PCN84 Preliminary Results of a Cost Effectiveness MODEL of Atezolizumab PLUS Bevacizumab in Unresectable Hepatocellular Carcinoma (HCC) in France
Value in Health
◽
10.1016/j.jval.2020.08.221
◽
2020
◽
Vol 23
◽
pp. S436
Author(s):
C. Dubois de Gennes
◽
B. Mazaleyrat
◽
J. Sanchez Alvarez
◽
H. Cawston
Keyword(s):
Hepatocellular Carcinoma
◽
Cost Effectiveness
◽
Preliminary Results
◽
Unresectable Hepatocellular Carcinoma
◽
Effectiveness Model
Download Full-text
Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
Rheumatology and Therapy
◽
10.1007/s40744-021-00308-w
◽
2021
◽
Author(s):
SiNi Li
◽
JianHe Li
◽
LiuBao Peng
◽
YaMin Li
◽
XiaoMin Wan
Keyword(s):
Rheumatoid Arthritis
◽
Cost Effectiveness
◽
Severe Rheumatoid Arthritis
Download Full-text
Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
PharmacoEconomics
◽
10.1007/s40273-021-01009-6
◽
2021
◽
Vol 39
(5)
◽
pp. 589-600
Author(s):
Edna Keeney
◽
Howard Thom
◽
Emma Turner
◽
Richard M. Martin
◽
Sabina Sanghera
Keyword(s):
Prostate Cancer
◽
Cost Effectiveness
◽
Cancer Screening
◽
Prostate Cancer Screening
◽
Model Application
◽
Modified Delphi
◽
Delphi Approach
◽
Effectiveness Model
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close